advertisement

---

Singh IP 8

Showing records 1 to 8 | Display all abstracts from Singh IP

117371 Alternatives to Topical Glaucoma Medication for Glaucoma Management
Bedrood S
Clinical Ophthalmology 2023; 17: 3899-3913

---

118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials
Dick HB
American Journal of Ophthalmology 2024; 260: 172-181

---

117371 Alternatives to Topical Glaucoma Medication for Glaucoma Management
Berdahl J
Clinical Ophthalmology 2023; 17: 3899-3913

---

118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials
Mackert MJ
American Journal of Ophthalmology 2024; 260: 172-181

---

117371 Alternatives to Topical Glaucoma Medication for Glaucoma Management
Sheybani A
Clinical Ophthalmology 2023; 17: 3899-3913

---

118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials
Ahmed IIK; Denis P
American Journal of Ophthalmology 2024; 260: 172-181

---

117371 Alternatives to Topical Glaucoma Medication for Glaucoma Management
Singh IP
Clinical Ophthalmology 2023; 17: 3899-3913

---

118339 Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials
Hirneiß C; Flowers BE; Singh IP; Mansouri K; Fea AM
American Journal of Ophthalmology 2024; 260: 172-181

---